Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole

T. J. Walsh, B. Moriyama, Scott Robert Penzak, T. E. Klein, K. E. Caudle

Research output: Contribution to journalLetter

4 Scopus citations
Original languageEnglish
Number of pages1
JournalClinical Pharmacology and Therapeutics
Issue number2
StatePublished - 1 Aug 2017

Cite this